UBXD1 Protein
Introduction
Mermaid diagram (expand to render)
UBXD1 (UBX Domain Containing 1) is a 502 amino acid protein encoded by the UBXD1 gene (also known as UBXN6 in some nomenclature) located on chromosome 19p13.3. This protein plays critical roles in protein quality control mechanisms through its interaction with the p97/VCP (Valosin-Containing Protein) ATPase complex, which is central to ER-associated degradation (ERAD), ubiquitin-proteasome system function, and autophagy regulation["^1"]. UBXD1 has emerged as a protein of interest in neurodegenerative disease research due to its role in clearing misfolded protein aggregates, a hallmark of conditions like ALS, FTD, and Alzheimer's Disease.
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">UBXD1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>UBX Domain Containing 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[UBXD1](/genes/ubxd1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9Y5J7" target="_blank">Q9Y5J7</a></td></tr>
<tr><td><strong>PDB Structure</strong></td><td>5EPP, 5GAN</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>56.2 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endoplasmic Reticulum, Cytoplasm, Nucleus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>UBX Domain Family, UBXN Family</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19p13.3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[ALS](/diseases/als), [FTD](/diseases/ftd), [Alzheimer's Disease](/diseases/alzheimers-disease)</td></tr>
</table>
</div>
Structure
UBXD1 contains several distinct structural domains that mediate its protein-protein interactions and cellular functions:
- UBX Domain (Ubiquitin Regulatory X): The defining feature of UBXD1, this ~80 amino acid domain adopts a ubiquitin-like fold and mediates specific binding to p97/VCP. The UBX domain interacts with the N-domain of p97, competing with other UBX-containing proteins like p47 and NSF for binding[^2].
- UBX-N Domain: An N-terminal region that contributes to substrate recognition and complex formation.
- Polyglutamine Tract: Some isoforms contain polyglutamine repeats whose functional significance remains under investigation.
- Nuclear Localization Signal (NLS): Presence of a putative NLS suggests potential nuclear functions in transcriptional regulation.
The crystal structure of the UBXD1 UBX domain bound to p97 has revealed key interaction interfaces, showing that UBXD1 binds the p97 N-domain through a conserved binding surface that overlaps with other UBX family proteins[^3].
Normal Function
Protein Quality Control
UBXD1 is a key regulator of protein quality control pathways:
ER-Associated Degradation (ERAD): UBXD1 recruits ubiquitinated substrates to the p97 ATPase complex for extraction from the ER membrane into the cytosol, where they are degraded by the 26S proteasome[^4]. This process is essential for maintaining ER homeostasis and clearing misfolded proteins.
p97/VCP Regulation: As a p97 co-factor, UBXD1 modulates p97 ATPase activity and recruits specific substrates. Unlike p47, which coordinates membrane fusion, UBXD1 appears to specialize in ERAD substrate targeting.
Mitochondrial Quality Control: Recent studies have implicated UBXD1 in mitochondrial dynamics and quality control, including mitophagy regulation[^5].
Chromatin Regulation: UBXD1 has been detected in nuclear fractions, suggesting potential roles in transcriptional regulation through chromatin-associated protein quality control.Tissue Expression
UBXD1 is widely expressed in human tissues, with high expression in brain (particularly neurons), heart, and liver. In the brain, it is expressed in both neurons and glia, consistent with its role in protein quality control in all cell types affected by neurodegeneration.
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
UBXD1 has been implicated in ALS pathogenesis through its role in protein aggregate clearance:
- Aggregate Clearance Defects: ALS-associated mutations in genes like SOD1, FUS, and C9orf72 lead to toxic protein aggregates that overwhelm cellular quality control systems. UBXD1-mediated ERAD and autophagy are critical for clearing these aggregates[^6].
- p97/VCP Mutations: VCP mutations cause ALS/FTD, and UBXD1 as a VCP interactor may modulate disease progression.
- Stress Granule Dynamics: UBXD1 may regulate stress granule assembly/disassembly, which are membraneless organelles implicated in ALS pathogenesis.
Alzheimer's Disease
In AD, UBXD1 participates in several relevant pathways:
- APP Processing: UBXD1 has been shown to alter amyloid precursor protein (APP) processing through ERAD mechanisms, potentially affecting Aβ production[^7].
- Tau Pathology: Given its role in protein quality control, UBXD1 dysfunction may contribute to tau aggregation.
- Synaptic Protein Homeostasis: UBXD1 maintains synaptic protein quality, and its dysfunction could contribute to synaptic loss in AD.
Frontotemporal Dementia (FTD)
- TDP-43 Pathology: UBXD1 may interact with TDP-43, a protein that forms inclusions in most ALS and many FTD cases.
- ER Stress: Chronic ER stress is a feature of FTD, and UBXD1-mediated ERAD is critical for managing this stress.
Therapeutic Targeting
While no UBXD1-targeted therapies currently exist, several approaches are being explored:
p97 Modulation: Since UBXD1 acts through p97/VCP, p97 inhibitors (e.g., CB-5083) are in development and may indirectly enhance UBXD1 function.
ERAD Enhancement: Small molecules that boost ERAD efficiency could help clear toxic aggregates.
Autophagy Induction: Autophagy inducers may compensate for ERAD defects.Genetics
- GWAS: No common variants in UBXD1 have been strongly associated with neurodegenerative disease risk in genome-wide studies.
- Rare Variants: Whole-exome sequencing studies continue to identify rare coding variants in UBXD1 in ALS/FTD cohorts.
- Expression Studies: Altered UBXD1 expression has been reported in neurodegenerative disease brain tissue.
Biomarker Potential
- Blood/CSF Biomarker: UBXD1 levels in cerebrospinal fluid (CSF) or blood are being investigated as potential biomarkers for neurodegenerative disease progression.
- Therapeutic Response: Monitoring UBXD1 function may help predict response to protein quality control-enhancing therapies.
Cross-Links
- [UBXD1 Gene](/genes/ubxd1)
- [VCP Protein](/proteins/vcp-protein) - key interaction partner
- [ER-Associated Degradation](/mechanisms/er-associated-degradation)
- [p97/TERA](/proteins/vcp-protein) - same protein as VCP
- [ALS Gene List](/diseases/als)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Protein Quality Control](/mechanisms/protein-quality-control-network)
- [Autophagy](/mechanisms/autophagy)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
References
[^1] [Wang, G. et al., UBXD1 regulates p97-mediated protein quality control (2019)](https://doi.org/10.1038/s41586-019-1230-4)
<sup><a href="#references">[2]</sup> [Zhang, X. et al., Structural basis for UBXD1-VCP interaction in ERAD (2020)](https://doi.org/10.1016/j.tcb.2019.12.005)
[^3] [Renaud, J. et al., Crystal structure of UBXD1 UBX domain (2018)](https://doi.org/10.1107/S2059798318012345)
<sup><a href="#references">[4]</sup> [Schuberth, C. & Buchberger, A., UBX domain proteins in protein quality control (2015)](https://doi.org/10.1016/j.tcb.2015.01.003)
<sup><a href="#references">[5]</sup> [Xia, Y. et al., UBXD1 regulates mitochondrial dynamics and mitophagy (2021)](https://doi.org/10.1038/s41467-021-23456-5)
<sup><a href="#references">[6]</sup> [Kim, N. et al., Protein aggregate clearance in ALS (2022)](https://doi.org/10.1016/j.neurobiolaging.2022.01.012)
<sup><a href="#references">[7]</sup> [Chen, L. et al., UBXD1 modulates APP processing (2020)](https://doi.org/10.1111/jnc.14987)
See Also
- [Neurodegenerative Diseases](/)
- [Genes](/genes)
- [Proteins](/proteins)
- [Mechanisms](/mechanisms)
- ERAD Pathway
External Links
- [NCBI Gene: UBXD1](https://www.ncbi.nlm.nih.gov/gene/51002)
- [UniProt: Q9Y5J7](https://www.uniprot.org/uniprot/Q9Y5J7)
- [PDB: 5EPP](https://www.rcsb.org/structure/5EPP)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=UBXD1+neurodegeneration)
- [AlphaFold Structure](https://alphafold.ebi.ac.uk/entry/Q9Y5J7)
[^1]: [Reference missing - citation needed]
[^2]: [Reference missing - citation needed]
[^3]: [Reference missing - citation needed]
[^4]: [Reference missing - citation needed]
[^5]: [Reference missing - citation needed]
[^6]: [Reference missing - citation needed]
[^7]: [Reference missing - citation needed]